280: ESMO highlights, Roivant's big deal, & biotech VC on the rise
The Readout Loud
00:00
Developments in Alzheimer's Disease Treatment at the CTAD Conference
The hosts discuss the recent CTAD conference in Boston, highlighting the introduction of a subcutaneous injection formulation for the approved Alzheimer's treatment drug Lakembi. Despite initial hopes of lower rates, they mention that the subcutaneous form has slightly higher rates of brain swelling and bleeds compared to the intravenous form.
Transcript
Play full episode
